Randy L Buckner Selected Research

Randy L Buckner Research Topics

8	Alzheimer Disease (Alzheimer's Disease) 02/2016 - 08/2005
5	Cognitive Dysfunction 01/2019 - 02/2002
5	Dementia (Dementias) 08/2016 - 06/2004
5	Atrophy 02/2015 - 09/2004
2	Schizophrenia (Dementia Praecox) 01/2022 - 04/2012
2	Mental Disorders (Mental Disorder) 10/2021 - 10/2014
2	Cerebral Cortical Thinning 06/2011 - 03/2009
1	Neurodevelopmental Disorders 01/2022
1	Disease Progression 08/2016
1	Amyloid Plaque 02/2016
1	Asphyxia (Suffocation) 12/2014
1	Panic Disorder (Panic Attack) 12/2014
1	Acidosis 12/2014
1	Hypersensitivity (Allergy) 12/2014
1	Nervous System Diseases (Neurological Disorders) 11/2012
1	Genetic Risk Score 11/2012
1	Temporal Lobe Epilepsy 04/2012
1	Pathologic Processes 03/2010
1	Neurologic Manifestations (Neurological Manifestations) 04/2007

10	Amyloid (Amyloid Fibrils)IBA 01/2019 - 08/2005
6	Biomarkers (Surrogate Marker)IBA 02/2016 - 04/2007
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	TabletsIBA 10/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2016
1	Dopamine (Intropin)FDA LinkGeneric 02/2016
1	Pharmaceutical PreparationsIBA 02/2015
1	Hypnotics and Sedatives (Sedatives)IBA 02/2015
1	Acid Sensing Ion ChannelsIBA 12/2014
1	Carbon DioxideIBA 12/2014
1	Indicators and Reagents (Reagents)IBA 11/2012
1	Apolipoproteins E (ApoE)IBA 11/2012
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 03/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2004

2	Cognitive Training 06/2004 - 02/2002
1	Transcranial Magnetic Stimulation 10/2014
1	Therapeutics 10/2014
1	Deep Brain Stimulation 10/2014